Normunity is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer.Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targetingnewly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer.Normunity is located in Boston, Massachusetts and West Haven, Connecticut.

Biotechnology

Health Care

Therapeutics

Normunity

This department focuses on managing and optimizing biometric data analysis and lab operations to support organizational objectives.

Biometric Services

This department focuses on scientific research and the development of new products and technologies.

Research and Development

This department manages administrative support and operational efficiency within the organization.

Administration and Operations

This department oversees the organization's board activities and ensures compliance with governance standards.

Board Governance

This department oversees the management and coordination of clinical trials and operational strategies within the medical domain.

Clinical Operations

This department oversees the strategic direction and overall management of the organization's scientific and medical initiatives.

People (0)

Jobs (0)

Other teams

Research and Development

Administration and Operations

Board Governance

Clinical Operations

Executive Leadership